The Board denied the veteran's claim for service connection for acute myeloblastic leukemia, finding that it was not incurred or aggravated in service and is not related to herbicide exposure.
The deciding factor: The evidence did not establish a direct link between the veteran's acute myeloblastic leukemia and his military service, including no in-service diagnosis of the condition. The Board also found insufficient evidence linking the disease to herbicide exposure as per the Secretary's determination based on the National Academy of Sciences' analysis.
- Claimed conditions
- acute myeloblastic leukemia
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- December 19, 2008
- Citation
- 0843830
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 0843830.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran's acute myeloblastic leukemia is granted as presumptively related to exposure at Camp LeJeune. The claim for essential thrombocythemia remains pending and requires a new VA medical opinion.
- Whole decision: Dismissed
The appeal of entitlement to service connection for acute myeloblastic leukemia was dismissed due to an invalid election of Board review.
- Whole decision: Dismissed
The appeal was dismissed due to the death of the appellant, who was substituted as claimant in May 2021.
- Whole decision: Remanded (sent back)
The Board has decided to remand the case due to uncertainty about whether the Veteran's leukemia is a chronic B-cell leukemia and to seek a VA medical opinion on the cause of his myelodysplastic syndrome, including AML.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.